OEC president and CEO David J. Rose has resigned his positions with the company, the SaltLake City-based manufacturer of mobile C-arms reported. Rose steppeddown a few weeks after OEC posted lower sales and earnings figuresfor 1994 (SCAN 2/1/95). OEC
OEC president and CEO David J. Rose has resigned his positions with the company, the SaltLake City-based manufacturer of mobile C-arms reported. Rose steppeddown a few weeks after OEC posted lower sales and earnings figuresfor 1994 (SCAN 2/1/95).
OEC chairman Ruediger Naumann-Etienne has assumed Rose's postswith the intention of improving operating results and growingthe company in 1995, both through operations and strategic acquisitions.Naumann-Etienne said OEC fell short of its financial objectiveslast year. Revenues for the year were off 1.8% to $98.2 millionand net income was down 11% to $8.7 million.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.